1 | 1 | | 81R2185 JSC-D |
---|
2 | 2 | | By: Van de Putte S.B. No. 1817 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to a voluntary statewide diabetes mellitus registry. |
---|
8 | 8 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
9 | 9 | | SECTION 1. The heading to Chapter 95, Health and Safety |
---|
10 | 10 | | Code, is amended to read as follows: |
---|
11 | 11 | | CHAPTER 95. [RISK ASSESSMENT FOR TYPE 2] DIABETES |
---|
12 | 12 | | SECTION 2. Chapter 95, Health and Safety Code, is amended by |
---|
13 | 13 | | designating Sections 95.001, 95.002, 95.003, 95.004, 95.005, and |
---|
14 | 14 | | 95.006 as Subchapter A and adding a heading to Subchapter A to read |
---|
15 | 15 | | as follows: |
---|
16 | 16 | | SUBCHAPTER A. RISK ASSESSMENT FOR TYPE 2 DIABETES |
---|
17 | 17 | | SECTION 3. Section 95.001, Health and Safety Code, is |
---|
18 | 18 | | amended to read as follows: |
---|
19 | 19 | | Sec. 95.001. DEFINITIONS. In this subchapter [chapter]: |
---|
20 | 20 | | (1) "Acanthosis nigricans" means a light brown or |
---|
21 | 21 | | black velvety, rough, or thickened area on the surface of the skin |
---|
22 | 22 | | that may signal high insulin levels indicative of insulin |
---|
23 | 23 | | resistance. |
---|
24 | 24 | | (1-a) "Advisory committee" means the Type 2 Diabetes |
---|
25 | 25 | | Risk Assessment Program Advisory Committee established under |
---|
26 | 26 | | Section 95.006. |
---|
27 | 27 | | (1-b) "Council" means the Texas Diabetes Council. |
---|
28 | 28 | | (3) "Office" means The University of Texas-Pan |
---|
29 | 29 | | American Border Health Office. |
---|
30 | 30 | | (4) "Professional examination" means an evaluation |
---|
31 | 31 | | performed by an appropriately licensed professional. |
---|
32 | 32 | | (5) "School" means an educational institution that |
---|
33 | 33 | | admits children who are five years of age or older but younger than |
---|
34 | 34 | | 21 years of age. |
---|
35 | 35 | | SECTION 4. Chapter 95, Health and Safety Code, is amended by |
---|
36 | 36 | | adding Subchapter B to read as follows: |
---|
37 | 37 | | SUBCHAPTER B. DIABETES MELLITUS REGISTRY |
---|
38 | 38 | | Sec. 95.051. DEFINITIONS. In this subchapter: |
---|
39 | 39 | | (1) "Department" means the Department of State Health |
---|
40 | 40 | | Services. |
---|
41 | 41 | | (2) "Executive commissioner" means the executive |
---|
42 | 42 | | commissioner of the Health and Human Services Commission. |
---|
43 | 43 | | (3) "Public health district" means a district created |
---|
44 | 44 | | under Chapter 121. |
---|
45 | 45 | | Sec. 95.052. DIABETES MELLITUS REGISTRY. (a) The |
---|
46 | 46 | | department, in coordination with participating public health |
---|
47 | 47 | | districts, shall create and maintain an electronic diabetes |
---|
48 | 48 | | mellitus registry to track the glycosylated hemoglobin level of |
---|
49 | 49 | | each person who has a laboratory test to determine that level |
---|
50 | 50 | | performed at a clinical laboratory in the participating district. |
---|
51 | 51 | | (b) A public health district may participate in the diabetes |
---|
52 | 52 | | mellitus registry. A public health district that participates in |
---|
53 | 53 | | the registry is solely responsible for the costs of establishing |
---|
54 | 54 | | and administering the program in that district. |
---|
55 | 55 | | (c) A clinical laboratory located in a participating public |
---|
56 | 56 | | health district shall submit to the district and the department the |
---|
57 | 57 | | results of each glycosylated hemoglobin test that the laboratory |
---|
58 | 58 | | performs. |
---|
59 | 59 | | (d) The department and participating district shall: |
---|
60 | 60 | | (1) compile results submitted under Subsection (c) in |
---|
61 | 61 | | order to track: |
---|
62 | 62 | | (A) the prevalence of diabetes mellitus among |
---|
63 | 63 | | people tested in the district; |
---|
64 | 64 | | (B) the level of control the patients in each |
---|
65 | 65 | | demographic group exert over the diabetes mellitus; |
---|
66 | 66 | | (C) the trends of new diagnoses of diabetes |
---|
67 | 67 | | mellitus in the district; and |
---|
68 | 68 | | (D) the health care costs associated with |
---|
69 | 69 | | diabetes mellitus; and |
---|
70 | 70 | | (2) promote discussion and public information |
---|
71 | 71 | | programs regarding diabetes mellitus. |
---|
72 | 72 | | Sec. 95.053. CONFIDENTIALITY. (a) Reports, records, and |
---|
73 | 73 | | information obtained under this subchapter are confidential, |
---|
74 | 74 | | privileged, not subject to disclosure under Chapter 552, Government |
---|
75 | 75 | | Code, and not subject to subpoena, and may not otherwise be released |
---|
76 | 76 | | or made public except as provided by this subchapter. The reports, |
---|
77 | 77 | | records, and information obtained under this subchapter are for the |
---|
78 | 78 | | confidential use of the department and the public health district |
---|
79 | 79 | | and the persons or public or private entities that the department |
---|
80 | 80 | | and participating district determine are necessary to carry out the |
---|
81 | 81 | | provisions of this subchapter. |
---|
82 | 82 | | (b) Medical or epidemiological information may be released: |
---|
83 | 83 | | (1) for statistical purposes in a manner that prevents |
---|
84 | 84 | | identification of individuals, health care facilities, clinical |
---|
85 | 85 | | laboratories, or health care practitioners; |
---|
86 | 86 | | (2) with the consent of each person identified in the |
---|
87 | 87 | | information; or |
---|
88 | 88 | | (3) to promote diabetes mellitus research, including |
---|
89 | 89 | | release of information to other diabetes registries and appropriate |
---|
90 | 90 | | state and federal agencies, under rules adopted by the executive |
---|
91 | 91 | | commissioner to ensure confidentiality as required by state and |
---|
92 | 92 | | federal laws. |
---|
93 | 93 | | (c) An employee of this state or a public health district |
---|
94 | 94 | | may not testify in a civil, criminal, special, or other proceeding |
---|
95 | 95 | | as to the existence or contents of reports, records, or information |
---|
96 | 96 | | concerning an individual whose medical records have been used in |
---|
97 | 97 | | submitting data required under this subchapter unless the |
---|
98 | 98 | | individual consents in advance. |
---|
99 | 99 | | (d) Reports, records, or information furnished to the |
---|
100 | 100 | | diabetes mellitus registry under this subchapter or a diabetes |
---|
101 | 101 | | researcher under Subsection (b) is for the confidential use of the |
---|
102 | 102 | | diabetes mellitus registry or the diabetes researcher, as |
---|
103 | 103 | | applicable, and is subject to Subsection (a). |
---|
104 | 104 | | Sec. 95.054. RULES. The executive commissioner shall adopt |
---|
105 | 105 | | rules to implement this subchapter, including rules to govern the |
---|
106 | 106 | | format and method of collecting glycosylated hemoglobin data. |
---|
107 | 107 | | Sec. 95.055. REPORT. Not later than December 1 of each |
---|
108 | 108 | | even-numbered year, the department shall submit to the governor, |
---|
109 | 109 | | lieutenant governor, speaker of the house of representatives, and |
---|
110 | 110 | | appropriate standing committees of the legislature a report |
---|
111 | 111 | | regarding the diabetes mellitus registry that includes an |
---|
112 | 112 | | evaluation of the effectiveness of the registry and the number of |
---|
113 | 113 | | public health districts voluntarily participating in the registry. |
---|
114 | 114 | | SECTION 5. This Act takes effect September 1, 2009. |
---|